Page last updated: 2024-09-04

vatalanib and Pleural Effusion, Malignant

vatalanib has been researched along with Pleural Effusion, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bucana, CD; Fidler, IJ; Herbst, RS; Killion, JJ; Knighton, B; Shinohara, H; Wood, J; Yano, S	1

Other Studies

1 other study(ies) available for vatalanib and Pleural Effusion, Malignant

Article	Year
Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:3 Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Capillary Permeability; Cell Division; Cell Line; Endothelial Growth Factors; Endothelium, Vascular; Gene Expression Regulation; Humans; Immunohistochemistry; In Situ Hybridization; Lung Neoplasms; Lymphokines; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphorylation; Phthalazines; Pleural Effusion, Malignant; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000

Article

Year

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:3

Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Capillary Permeability; Cell Division; Cell Line; Endothelial Growth Factors; Endothelium, Vascular; Gene Expression Regulation; Humans; Immunohistochemistry; In Situ Hybridization; Lung Neoplasms; Lymphokines; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphorylation; Phthalazines; Pleural Effusion, Malignant; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000